Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Tendyne Holdings, Inc. is a clinical stage medical device company focused on the development of minimally invasive therapies for the treatment of mitral regurgitation. Mitral regurgitation is a condition that afflicts hundreds of thousands of individuals worldwide every year. Formed in 2010, their first product concept is a transcatheter mitral valve replacement prosthesis for the treatment of mitral regurgitation. The intent is for the valve to be deployed and secured with no disruption to the native mitral annulus while preserving the sub-valvular apparatus. Placement of the valve is intended to be completed transapically in a simple procedure where the implanting physician is able to re-position, remove, and re-deploy their valve throughout the procedure.

Heart Repair Technologies is a leader in the development of innovative products for cardiovascular medicine.

Edwards Lifesciences AG, a subsidiary of Edwards Lifesciences Corp., is a Swiss company located in Nyon that manufactures and distributes healthcare equipment.

Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

Part of Edwards Lifesciences Corp., Edwards Lifesciences LLC is a company headquartered in Irvine, CA. The firm develops and manufactures heart valves and hemodynamic monitoring systems. It was founded in 1958. Michael A. Mussallem has been the CEO since 2000.

Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Cephea Valve Technologies, Inc. provides catheter delivered mitral valve regurgitation products/heart valves for the treatment of coronary artery disease in patients. It offers catheter based therapies, such as balloons and stents for aortic valves replacements. The company was incorporated in 2011 and is based in San Jose, California.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Synergio is an expert consultancy in the area of corporate responsibility (CR) strategies. Synergio delivers strategic solutions, insights and advice to companies, enabling them to create long-term value by doing business sustainably. Synergio's deep knowledge of challenges and opportunities in sustainability ensures that they have the right tools and strategies to deliver solutions for responsible businesses. Working with diverse clients, Synergio navigate non-financial risk issues and utilise opportunities to gain competitive advantage. With a focus on achieving outcomes and a willingness to embrace innovation, Synergio pushes the boundaries for high engagement approaches in sustainability. Synergio's work has a strong commercial focus and is founded on evidence-based analyses and decision-making. Synergio's knowledge and expertise in environmental, social and economic issues, combined with their consulting, strategy and management experience, enables them to successfully integrate sustainability into business strategies to improve organisational performance. Synergio guides clients through the various stages of their sustainability journey whilst inspiring and facilitating the creation of overarching vision, goals, and long-term plans. Synergio also creates the business case for specific initiatives and recommend governance structures and measurement tools to ensure they are implemented effectively.

Immanuel Diakonie GmbH, part of Evangelisch-Freikirchliche Gemeinde Berlin-Schöneberg, is a company headquartered in Berlin, Germany. The firm operates clinics, medical care centres and senior living facilities.\nAn excerpt from the company's website reads as follows: Immanuel Diakonie has been active for over 70 years; today with around 3,100 employees at 68 locations in Brandenburg, Berlin, Hamburg, Thuringia, Mecklenburg-Western Pomerania, Hesse and Schleswig-Holstein. The corporate group includes clinics, medical care centers, senior citizen facilities as well as addiction care, disability assistance, child and youth services, psychosocial counseling, physiotherapy and occupational therapy.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.

Micor Ltd., a subsidiary of Super Group Ltd., is a South African company located in Isando that provides management consulting services.

CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).

MAQUET Cardiovascular LLC, a subsidiary of Getinge AB, is an American company located in Wayne, NJ. The firm develops and distributes therapeutic medical equipment.\nThe company says this about itself: Maquet is part of Getinge Group, a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge Group operates under the three brands of ArjoHuntleigh, Getinge and Maquet. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers �� improving the every-day life for people, today and tomorrow.